» Articles » PMID: 1656869

Quinolone Resistance-determining Region in the DNA Gyrase GyrB Gene of Escherichia Coli

Overview
Specialty Pharmacology
Date 1991 Aug 1
PMID 1656869
Citations 163
Authors
Affiliations
Soon will be listed here.
Abstract

Thirteen spontaneous quinolone-resistant gyrB mutants of Escherichia coli KL16, including two that were examined previously, were divided into two types according to their quinolone resistance patterns. Type 1 mutants were resistant to all the quinolones tested, while type 2 mutants were resistant to acidic quinolones and were hypersusceptible to amphoteric quinolones. Nucleotide sequence analysis disclosed that all nine type 1 mutants had a point mutation from aspartic acid to asparagine at amino acid 426 and that all four type 2 mutants had a point mutation from lysine to glutamic acid at amino acid 447.

Citing Articles

Structural basis of chiral wrap and T-segment capture by DNA gyrase.

Michalczyk E, Pakosz-Stepien Z, Liston J, Gittins O, Pabis M, Heddle J Proc Natl Acad Sci U S A. 2024; 121(49):e2407398121.

PMID: 39589884 PMC: 11626157. DOI: 10.1073/pnas.2407398121.


Antibiotic Resistance of : Mechanisms and Clinical Implications.

Hasanuzzaman M, Bang C, Gong E J Korean Med Sci. 2024; 39(4):e44.

PMID: 38288543 PMC: 10825452. DOI: 10.3346/jkms.2024.39.e44.


Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.

Thapa J, Chizimu J, Kitamura S, Akapelwa M, Suwanthada P, Miura N Microbiol Spectr. 2023; 11(3):e0508822.

PMID: 37067420 PMC: 10269562. DOI: 10.1128/spectrum.05088-22.


Fluoroquinolones Are Useful as Directed Treatment for Complicated UTI in a Setting with a High Prevalence of Quinolone-Resistant Microorganisms.

Artero A, Lopez-Cruz I, Piles L, Alberola J, Eiros J, Salavert S Antibiotics (Basel). 2023; 12(1).

PMID: 36671384 PMC: 9854898. DOI: 10.3390/antibiotics12010183.


Intracellular Experimental Evolution of Subsp. Live Vaccine Strain (LVS) to Antimicrobial Resistance.

Mehta H, Song X, Shamoo Y ACS Infect Dis. 2023; 9(2):308-321.

PMID: 36662533 PMC: 9996545. DOI: 10.1021/acsinfecdis.2c00483.


References
1.
Shen L, Mitscher L, Sharma P, ODonnell T, Chu D, Cooper C . Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model. Biochemistry. 1989; 28(9):3886-94. DOI: 10.1021/bi00435a039. View

2.
Wang J . DNA topoisomerases. Annu Rev Biochem. 1985; 54:665-97. DOI: 10.1146/annurev.bi.54.070185.003313. View

3.
Shen L, Kohlbrenner W, Weigl D, Baranowski J . Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes. J Biol Chem. 1989; 264(5):2973-8. View

4.
Nakamura S, Nakamura M, Kojima T, Yoshida H . gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother. 1989; 33(2):254-5. PMC: 171470. DOI: 10.1128/AAC.33.2.254. View

5.
Nakamura S, Minami A, Nakata K, Kurobe N, Kouno K, Sakaguchi Y . In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone. Antimicrob Agents Chemother. 1989; 33(8):1167-73. PMC: 172618. DOI: 10.1128/AAC.33.8.1167. View